Results 211 to 220 of about 12,324,592 (318)
Approach to difficult clinical communications in acute and critical care settings. [PDF]
Ng IKS, Chong KM, Teo DB, See KC.
europepmc +1 more source
Developmental and Epileptic Encephalopathy due to Biallelic Pathogenic Variants in PIGM
ABSTRACT Objective PIGM encodes a critical enzyme in the glycosylphosphatidylinositol (GPI)‐anchor biosynthesis pathway. While promoter‐region mutations in PIGM have been associated with a relatively mild phenotype characterized by portal vein thrombosis and absence seizures, recent evidence suggests that coding‐region mutations result in a more severe
Júlia Sala‐Coromina +11 more
wiley +1 more source
Electroencephalogram Monitoring in Critical Care: Multicenter Analysis of Timing, Duration, and Readmissions. [PDF]
Tăuțan AM +11 more
europepmc +1 more source
FDG‐PET Associations With Disease Severity and Outcomes in NMDA‐Receptor IgG Autoimmune Encephalitis
ABSTRACT Background Patients with N‐methyl‐D‐aspartate (NMDA) receptor‐immunoglobulin G (IgG) autoimmune encephalitis (NMDAR‐IgG AE) demonstrate occipital lobe hypometabolism on baseline brain fluorodeoxyglucose‐positron emission tomography (bFDG‐PET).
Jonathan K. Lee +7 more
wiley +1 more source
Socioeconomic Status, Rurality, and Pediatric Critical Care Admission.
Bone JN +6 more
europepmc +1 more source
Socioeconomic status and critical care outcomes: Time for ICNARC to reconsider? [PDF]
Gilbert-Kawai N, Syratt T.
europepmc +1 more source
A Systematic Review and Meta‐Analysis of the Recurrence of Autoimmune Encephalitis
ABSTRACT Objective Autoimmune encephalitis (AE) is a disease with a potential for recurrence, and patients receive immunotherapy to prevent it. However, there is no consensus on the duration of immunotherapy. This study aimed to determine the recurrence rate and identify the risk factors for AE to provide guidance on the duration of immunotherapy ...
Shangkai Bai +5 more
wiley +1 more source
The 2025 Brazilian methanol poisoning crisis: a critical care and emergency medicine review. [PDF]
Beltrami FG +2 more
europepmc +1 more source

